Loading...

MGX METAGENOMI THERAPEUTICS INC Expansion Plans 8-K Filing

MTGN

MGX

METAGENOMI THERAPEUTICS INC

(MGX)

2025 8-K

Financial Results Update

Name Change Announcement

Financial Update

License Agreement Signed

Product Expansion

Financial Statements

Financial Results

Board Appointment

Data Presentation

Financial Results

Gene Therapy Update

External Links:

On May 14, 2025, Metagenomi, Inc. announced that they presented three abstracts at the ASGCT 28th Annual Meeting from May 13-17, 2025. This event highlights the company’s ongoing contributions to gene and cell therapy.

AI Assistant

METAGENOMI THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.